tiprankstipranks
Kymera Therapeutics, Inc. (KYMR)
NASDAQ:KYMR
US Market
KYMR
Kymera Therapeutics
RESEARCH TOOLSreports

Kymera Therapeutics (KYMR) Income Statement

423 Followers

Kymera Therapeutics Income Statement

Last quarter (Q4 2025), Kymera Therapeutics's total revenue was $2.86M, a decrease of -61.32% from the same quarter last year. In Q4, Kymera Therapeutics's net income was $-87.03M. See Kymera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 39.20M$ 47.07M$ 78.59M$ 46.83M$ 72.83M
Gross Profit
$ 39.20M$ 47.07M$ 78.59M$ 46.83M$ 72.83M
Operating Expenses
$ 388.60M$ 308.71M$ 244.12M$ 208.08M$ 173.36M
Depreciation and Amortization
$ 8.31M$ 7.37M$ 3.56M$ 2.98M$ 2.40M
EBITDA
$ -303.06M$ -216.24M$ -143.20M$ -151.66M$ -97.64M
Operating Income
$ -349.40M$ -261.63M$ -165.53M$ -161.26M$ -100.53M
Other Income/Expenses
$ 37.78M$ 37.78M$ 18.57M$ 6.45M$ 313.00K
Pretax Income
$ -311.62M$ -223.86M$ -146.96M$ -154.81M$ -100.22M
Net Income
$ -311.40M$ -223.86M$ -146.96M$ -154.81M$ -100.22M
Per Share Metrics
Basic EPS
$ -3.69$ -2.98$ -2.52$ -2.87$ -2.09
Diluted EPS
$ -3.69$ -2.98$ -2.52$ -2.87$ -2.09
Weighted Average Shares Outstanding
 84.39M 75.04M 58.37M 53.93M 47.99M
Weighted Average Shares Outstanding (Diluted)
 84.39M 75.04M 58.37M 53.93M 47.99M
Currency in USD

Kymera Therapeutics Earnings and Revenue History